$21.070
-0.771 (-3.66%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CGAU Prediction & Forecast by Similar Chart Analysis
Alphio's CGAU stock price prediction model matches the current Centerra Gold Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $21.99 (+0.08%). The 1-week path is $22.31 (+1.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Centerra Gold Inc Stock?
Centerra Gold Inc (CGAU) is a good buy right now, trading at $22.54 with a strong year-to-date change of +59.41%. The company has shown significant earnings growth, reporting a Q2 profit of $72.1 million, which translates to an EPS of $0.35, up from $0.32 last year. Additionally, the gross margin has improved to 35.92% in Q2 2026, indicating effective cost management. The main risk is the forward P/E ratio of 12.61, which suggests that the stock may be overvalued if earnings do not continue to grow as expected.
CGAU stock price ended at $21.07 on Wednesday, after losing -3.66%
Centerra Gold Inc (CGAU) last closed at $21.97, gaining +4.27%. These facts feed the 1-day and 1-week CGAU price prediction above.
Forecast Drivers
Centerra Gold Inc (CGAU) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CGAU, ranked by similarity.
Seasonality analysis for CGAU
Historically the probability of a positive October return for CGAU is 100.00%. May offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.